Arch Therapeutics Inc (ARTH)

[whatworld]

Why would Norchi risk his wad in China, especially after the company just secured enough financing to last through internal trials, CE app and the balance of the the year? He is not playing a weak hand here and there is no reason to suspect the patents that are recognized in Hong Kong, which is now under Chinese law, will be violated. We don't need a Hail Mary at this point and he won't call one.

Call me an optimist, but I see this presentation as a plus.